Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Meisel

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Cytotherapy|May 27, 2014
Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applicationsPatrick Wuchter, Karen Bieback, Hubert Schrezenmeier, et al.
Blood Advances|January 30, 2024
Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCTClaus-Philipp Maier, Chihab Klose, Christian Martin Seitz, et al.
Bone Marrow Transplantation|February 7, 2024
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppressionBarbara Meissner, Peter Lang, Peter Bader, et al.
Bone Marrow Transplantation|December 25, 2021
Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patientsWolfgang A Bethge, Matthias Eyrich, Stephan Mielke, et al.
British Journal of Haematology|December 2, 2017
Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trialMichaela Kuhlen, Andre M Willasch, Jean-Hugues Dalle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2015
Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trialChristina Peters, Martin Schrappe, Arend von Stackelberg, et al.
Pediatric Blood & Cancer|July 4, 2020
Risk factors for mixed chimerism in children with hemophagocytic lymphohistiocytosis after reduced toxicity conditioningKatharina Wustrau, Johann Greil, Karl-Walter Sykora, et al.
Bone Marrow Transplantation|August 6, 2020
Correction: ABO incompatibile graft management in pediatric transplantationAdriana Balduzzi, Halvard Bönig, Andrea Jarisch, et al.
American Journal of Hematology|May 17, 2019
Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWPHerbert Pichler, Anita Lawitschka, Evgenia Glogova, et al.
Haematologica|August 18, 2025
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM TrialAdriana Balduzzi, Evgenia Glogova, Christina Peters, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Cytotherapy|May 27, 2014
Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applicationsPatrick Wuchter, Karen Bieback, Hubert Schrezenmeier, et al.
Blood Advances|January 30, 2024
Influence of ATLG serum levels on CD3/CD19-depleted hematopoietic grafts and on immune recovery in pediatric haplo-HSCTClaus-Philipp Maier, Chihab Klose, Christian Martin Seitz, et al.
Bone Marrow Transplantation|February 7, 2024
Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppressionBarbara Meissner, Peter Lang, Peter Bader, et al.
Bone Marrow Transplantation|December 25, 2021
Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patientsWolfgang A Bethge, Matthias Eyrich, Stephan Mielke, et al.
British Journal of Haematology|December 2, 2017
Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trialMichaela Kuhlen, Andre M Willasch, Jean-Hugues Dalle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2015
Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trialChristina Peters, Martin Schrappe, Arend von Stackelberg, et al.
Pediatric Blood & Cancer|July 4, 2020
Risk factors for mixed chimerism in children with hemophagocytic lymphohistiocytosis after reduced toxicity conditioningKatharina Wustrau, Johann Greil, Karl-Walter Sykora, et al.
Bone Marrow Transplantation|August 6, 2020
Correction: ABO incompatibile graft management in pediatric transplantationAdriana Balduzzi, Halvard Bönig, Andrea Jarisch, et al.
American Journal of Hematology|May 17, 2019
Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWPHerbert Pichler, Anita Lawitschka, Evgenia Glogova, et al.
Haematologica|August 18, 2025
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM TrialAdriana Balduzzi, Evgenia Glogova, Christina Peters, et al.
Pageof 13